TY  - GEN
AU  - Zhao,Lingdi
AU  - Han,Lu
AU  - Zhang,Yong
AU  - Li,Tiepeng
AU  - Yang,Yonghao
AU  - Li,Wei
AU  - Shang,Yiman
AU  - Lin,Hongwei
AU  - Gao,Quanli
TI  - Combination of PD-1 blockade and RetroNectin
SN  - 1750-7448
PY  - 2019///0822
KW  - Adult
KW  - Antibodies, Monoclonal, Humanized
KW  - therapeutic use
KW  - Carcinoma, Non-Small-Cell Lung
KW  - immunology
KW  - Cells, Cultured
KW  - Combined Modality Therapy
KW  - Cytokine-Induced Killer Cells
KW  - Female
KW  - Fibronectins
KW  - Humans
KW  - Immunotherapy, Adoptive
KW  - methods
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Neoplasm Staging
KW  - Nivolumab
KW  - Programmed Cell Death 1 Receptor
KW  - antagonists & inhibitors
KW  - Recombinant Proteins
KW  - Retrospective Studies
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.2217/imt-2018-0125
ER  -